In harmony, co-therapy with OAd-expressing TRAIL and another type of immunostimulant cytokine (IL-24) has been previously reported to be associated with potent activation in caspase pathway, particularly caspases-3 and -8, and apoptosis promotion in HCC [14]. Here, TNFSF10 is linked to hepatocellular carcinoma.